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Summary
As a highly motivated social behavior, maternal behavior in rats has been routinely used to study 
psychoactive drugs for clinical, neuroscience and pharmacological purposes. Recent evidence 
indicates that acute activation of serotonin 2C (5-HT2C) receptors causes a disruption of rat 
maternal behavior. The present study was designed to elucidate the behavioral, pharmacological 
mechanisms and neuroanatomical basis of this 5-HT2C effect. First, we replicated the finding that 
acute MK212 injection (2.0 mg/kg, a highly selective 5-HT2C agonist) disrupts maternal behavior, 
especially on pup retrieval. Interestingly, this disruption was significantly attenuated by 4-h pup 
separation (a procedure putatively increased maternal motivation). MK212 also suppressed food 
retrieval, indicating that it has a general effect on motivated behaviors. Second, we showed that 
MK212 disrupts maternal behavior by specifically activating 5-HT2C receptor, as pretreatment 
with a 5-HT2C receptor antagonist SB242084 (0.6 and 1.0 mg/kg) alleviated MK212-induced 
disruption on pup retrieval. Third, we microinjected MK212 into various brain regions implicated 
in the regulation of maternal behavior: nucleus accumbens shell (25, 75, 250 ng/0.5μl/side), medial 
prefrontal cortex (25 and 250 ng, 1, 2 and 5 μg/0.5μl/side), and medial preoptic area (MPOA, 75 
ng, 1 and 5 μg/0.5μl/side). Pup retrieval and other maternal responses were not affected by any of 
these manipulations. Finally, we used c-Fos immunohistochemistry to identify the central 
mechanisms of the acute and repeated MK212 effects on maternal behavior. Acute MK212 (2.0 
mg/kg) disrupted pup retrieval and concurrently decreased c-Fos expression in the ventral part of 
lateral septal nucleus (LSv), MPOA, dentate gyrus (DG) and dorsal raphe (DR), but increased it in 
the central amygdala (CeA). Five days of repeated MK212 (2.0 mg/kg) treatment produced a 
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persistent disruption of pup retrieval and only decreased c-Fos expression in the DR. These 
findings not only confirm a role of 5-HT2C receptor in rat maternal behavior, but also suggest that 
the coordinated 5-HT2C activity in various limbic (e.g., LSv, DG, CeA), hypothalamic regions 
(e.g., MPOA) and brainstem areas (e.g. DR), is likely involved in the mediation of important 
psychological processes (e.g. motor function, motivation) necessary for the normal expression of 
maternal behavior.
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Serotonin 2C receptor; MK212; SB242084; Maternal behavior; Maternal motivation; Pup retrieval
1. Introduction
Maternal behavior in rats provides a valuable social interaction model with high ecological 
validity for the study of the neurobiological mechanisms of mothering and psychoactive 
drugs in a social domain (Fleming and Corter, 1988; Fleming and Corter, 1995; Li, 2015). 
Much research on the neurochemical basis of maternal behavior has been focusing on the 
mesolimbic and mesocortical dopamine (DA) systems (Afonso et al., 2007; Febo et al., 
2010; Hansen et al., 1991; Keer and Stern, 1999; Li and Fleming, 2003a, b; Numan, 2007; 
Numan et al., 2005). For example, both dopamine D1 and D2 receptors in the nucleus 
accumbens and medial preoptic area (MPOA) are involved in the regulation of maternal 
behavior (Numan et al., 2005; Stolzenberg et al., 2007; Stolzenberg et al., 2010), as 
activation or blockade of either receptor by psychoactive drugs (e.g. apormorphine and 
haloperidol) impairs maternal response in rats (Giordano et al., 1990; Keer and Stern, 1999; 
Silva et al., 2001).
Recent work suggests that serotonin, via its actions on 5-HT2A and 5-HT2C receptors, also 
plays an important role in the mediation of maternal behavior in rats. First, atypical 
antipsychotic drugs (e.g. clozapine) which possess potent antagonist actions against 5-
HT2A/2C receptors, dose-dependently disrupt active components of maternal behavior, such 
as pup retrieval, pup licking and nest building (Li et al., 2005; Li et al., 2004). Second, acute 
administration of 2,5-dimethoxy-4-iodo-amphetamine (DOI, a selective 5-HT2A/2C agonist) 
disrupts maternal performance, whereas pretreat of DOI dose-dependently reverses the 
clozapine (CLZ)-induced maternal disruption, suggesting that both activation and blockade 
of 5-HT2A and/or 5-HT2C receptors affect maternal behavior (Zhao and Li, 2009a, 2010). 
Finally, acute systemic injection of MK212, a highly selective 5-HT2C receptor agonist, also 
disrupts active components of rat maternal behavior in a dose-dependent fashion (Chen et 
al., 2014). Overall, it is clear that 5-HT2C receptor plays a regulatory role in maternal 
behavior, although much of the evidence comes from acute pharmacological studies and the 
specific mechanisms at various levels have not been elucidated.
The present study was designed to investigate the behavioral, pharmacological, and 
neuroanatomical mechanisms underlying the 5-HT2C receptor action in maternal behavior. 
Behaviorally, we employed two techniques. One was pup separation, a procedure putatively 
increasing maternal motivation. Removing pups from dams for several hours (> 3 h) prior to 
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maternal behavior testing is shown to restore pup retrieval deficits induced by massive 
dopamine depletion (Hansen, 1994), or reverse CLZ-induced disruption on maternal 
performance (Zhao and Li, 2009b). We treated our subjects with MK212 and tested them 
under the pup-separation (4 h) and no-pup-separation conditions, respectively. If pup-
separation is able to antagonize the effect of MK212, it would suggest that at least some 
aspect of the MK212’s disruption was due to its effect on animals’ motivation. The second 
technique was food-hoarding test, as a nonmaternal motivated behavior to compare and 
determine the nature of observed pup retrieval deficits (Numan, 1990; Numan and 
Corodimas, 1985). Because pup and food retrieval share some basic psychological 
processes, such as oral sensorimotor, incentive motivation, and sequential organization of 
motor acts (Whishaw et al., 1990), if MK212 also disrupts food retrieval, then 5-HT2C 
receptor might be broadly involved in motivated behaviors and its role is not maternally 
specific. Pharmacologically, we used a highly selective 5-HT2C receptor antagonist 
SB242084 (Kennett et al., 1997) and determined the receptor specific effect of MK212. 
Neuroanatomically, we also employed two approaches. One was the microinjection. MK212 
was microinjected into various brain regions implicated in the regulation of maternal 
behavior, such as the nucleus accumbens shell (NAs) (Li and Fleming, 2003a, b), medial 
prefrontal cortex (mPFC) (Afonso et al., 2007; Febo et al., 2010), and MPOA (Numan et al., 
1977; Stack et al., 2002) and maternal behavior was tested using a within-subjects design. 
The second approach was the c-Fos immunohistochemistry. We examined both acute and 
repeated treatment effects of MK212 (2.0 mg/kg) on c-Fos expression in various brain 
regions (NAs, mPFC and dorsal raphe, etc.).
2. Materials and methods
2.1. Animals
Naïve pregnant female Sprague-Dawley rats (gestational days 6 upon arrival to the animal 
facility) were purchased from Charles River Inc. All rats were housed individually in 48.3 
cm × 26.7 cm × 20.3 cm transparent polycarbonate cages under 12-h light/dark conditions 
(lights on at 6:30 am), and had access to standard laboratory rat chow and tap water ad 
libitum. The colony was maintained with a controlled temperature (21 ± 1 °C) and a relative 
humidity of 45–60%. Experiments were conducted during the light cycle. All animal 
manipulations were reviewed and approved by the University of Nebraska Institutional 
Animal Care and Use Committee, and were carried out in compliance with the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals.
2.2. Drugs and choices of dosage
MK212 [6-Chloro-2-(l-piperazinyl) pyrazine hydrochloride] and SB242084 [6-Chloro-2,3-
dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridiny]-1H-indole-1-carboxyamide 
dihydrochloride hydrate] were obtained from Tocris Bioscience (Ellisville, MO, USA). 
MK212 was dissolved in 0.9% saline and administrated subcutaneously at 2.0 mg/kg except 
central infusion study in Experiment 3. This dose of MK212 produces a reliable disruption 
on maternal behavior (Chen et al., 2014). For the central infusion, various doses of MK212 
(primarily based on relevant published studies) were microinjected into different brain 
regions (Filip and Cunningham, 2002, 2003; Pentkowski et al., 2010): 25 ng, 75 ng, 250 ng/
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0.5μl/side for NAs; 75 ng, 1.0 μg, 5.0 μg/0.5μl/side for MPOA; 25 ng, 250ng, 1 μg, 2μg, 
5μg/0.5 μl/side for mPFC. The bilateral microinjection (0.5 μl at 0.5μl/min) started 1 min 
after the insertion of the injector, which remained in place for an additional 1 min before 
removal to allow for drug diffusion. In present study, 0.9% saline was used as vehicle for 
MK212. SB242084 was dissolved in 30% dimethyl sulfoxide (DMSO) mixed with saline 
(VEH-1) and injected subcutaneously at the doses of 0.6 and 1.0 mg/kg. These doses are in 
the range of effective doses (0.2 mg/kg to 1.0 mg/kg) found in several recent reports 
(Boulougouris et al., 2008; Burghardt et al., 2007; Strong et al., 2009).
2.3. Basic experimental procedure and maternal behavior test
The basic procedure was identical to what has been described in our previous studies (Chen 
et al., 2014; Zhao and Li, 2009b). Starting 2 or 3 days prior to the first possible expected 
parturition date, the subjects were monitored every morning and afternoon for signs of 
parturition. Once the dam was found with pups in the morning (that day was designated as 
postpartum day 1, PP1) or in the afternoon (PP 0), two shredded paper towels were provided 
for nesting materials. On PP 2, each litter was culled to 8 pups (4 males and 4 females with 
the most visible milk bands) and all subjects were changed to clean observation cages with 
their litter.
Maternal behavior test was initiated by taking the eight pups away from the mother and 
destroying the nest. Ten seconds later, the pups were placed in the corner of the cage 
diagonal to the nest site or dam sleeping corner. Each test was recorded by video cameras 
and analyzed manually using a laptop computer with an event-recording program (JWatcher, 
http://www.jwatcher.ucla.edu). The raters were blind to each subject’s drug condition. The 
following behaviors were recorded and analyzed: pup retrieval (a rat picking up a pup in her 
mouth and carrying it back to the nest site), pup nursing (a rat positioning herself over the 
pups with legs splayed to accommodate the pups, including hover, high and low crouching-
over posture), pup licking (female rat placing its tongue on the anogenital area and the rest 
of a pup’s body), nest building (a rat picking up nest material in her mouth and transporting 
it back to the nest site or pushing the material with her forepaws towards the nest site). The 
first pup retrieval latency was defined as the time elapsed from the first pup approach to the 
retrieval of the first pup into the nest. 600s was assigned to non-responders who did not 
approach or retrieve the testing pups. After the test, unretrieved pups were returned to the 
nest site. On PP 2 or 3, to screen for baseline maternal performance and habituate dams to 
the maternal behavioral testing procedure, we conducted one maternal behavior test 
(removing pups then return them 10 s later), which was not video-recorded nor analyzed.
2.4. Experiment 1: Effect of pup separation on MK212-induced maternal disruption of pup 
retrieval: A comparison with food retrieval test
In this experiment, two groups of postpartum rats (MK212-2.0mg/kg, n = 16; VEH, n = 15) 
were used. A series of maternal behavior tests were conducted on PP 4 and 6. On each test 
day, maternal behavior was observed for 10 min at 4 time points, with the first one at 0.5 h 
before the drug injections (i.e., baseline), and the rest being carried out at 0.5, 2 and 4 h after 
the injections. These test time points were chosen primarily based on our and others’ 
MK212 studies (Chen et al., 2014; de Mello Cruz et al., 2005). We performed a cross-over 
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design. On PP 4, mother rats were allocated at random to receive either MK212 (n = 8) or 
VEH treatment (n = 7) and tested under the pup-separation (PS) condition in which their 
pups were taken away from them 4 h before the baseline test (0.5 h before the drug 
injection) on that day. Pups were removed from the mothers and placed into a bowl with 
nesting material on a temperature-controlled heating pad (34°C). The other dams (n = 8 for 
MK212; n = 8 for VEH) were tested without separation from their pups (no-pup-separation 
condition, NS). On PP 6, the same procedure was applied, but the rats tested in the pup-
separation condition on Day 4 were tested in the no-pup-separation condition, and ones 
previously tested in the no-pup-separation condition were tested in the pup-separation 
condition (a complete counterbalanced design).
This cross-over design allowed us to consecutively test each subject which received two 
experimental manipulations during the course of the experiment. Various measures of 
maternal behavior were recorded (see below for testing details). The food hoarding tests 
were conducted on PP 8 and 10. Two testing conditions were used: 6-h food-deprivation and 
no-food-deprivation. The basic procedure was adopted from previous studies (Numan and 
Corodimas, 1985; Whishaw et al., 1990). Before each test, pups were taken away and nests 
were destroyed. Ten seconds later, eight Supreme Mini-Treats™ Chocolate Flavor food 
pellets were placed in the front of the cage. Video recording started immediately after the 
placement of pellets for 10 min. At the end of each test, unretrieved and unconsumed pellets 
were removed, and the pups were returned to the dams. Number of retrieved pellets and 
retrieval latency was recorded.
2.5. Experiment 2: Receptor specificity of MK212’s disruptive effect on pup retrieval
In this study, we tested 7 postpartum rats using a within-subjects Latin square design to see 
if pretreatment of SB242084 (0.6 and 1.0 mg/kg) could attenuate the disruptive effect of 
MK212 (2.0 mg/kg) on pup retrieval. These doses of SB242084 were chosen based on 
several recent reports (Boulougouris et al., 2008; Burghardt et al., 2007; Strong et al., 2009). 
In addition, our own pilot study did not find any pup retrieval disruption by acute injection 
of SB242084 at 0.2, 0.6 and 1.0 mg/kg (unpublished data). Thus, any reversal effect of 
SB242084 could only be attributed to its counteraction again MK212. On PP 4, 6, 8, and 10, 
mother rats were randomly assigned to receive either a double injection of VEH-1 + VEH, 
VEH-1 + MK212, SB242084-0.6 + MK212, or SB242084-1.0 + MK212. All rats were 
tested under all the treatment conditions on every other day, so they served as their own 
controls. VEH-1 or SB242084 was injected 10 min before the MK212. Maternal behavior 
was tested for 10 min at 30 min before, 30 min, 60 min and 24 h after MK212 injection. 
Number of pups retrieved during the 10 min test period was used as the major index of 
MK212 effect and the reversal effect of SB242084.
2.6. Experiment 3: Neural basis of MK212’s effects on maternal behavior: a microinjection 
study
In this experiment, we attempted to identify the brain sites where MK212 acts to disrupt 
maternal behavior by centrally infusing MK212 into the NAs, MPOA or mPFC, three 
possible sites implicated in the action of MK212 (de Almeida et al., 2006; Liu et al., 2007; 
Pentkowski et al., 2010). On day 11–13 of gestation, rats were anaesthetized using a mixture 
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of ketamine HCl (90 mg/kg) and xylazine (4 mg/kg) (ip), and implanted with bilateral 
stainless-steel guide cannulas (22 gauge; Plastics One, Inc.) into the NAs (n = 6), MPOA (n 
= 7) or mPFC (n = 12). The incisor bar was set at −3.4 mm. The stereotaxic coordinates for 
the NAs were: anteroposterior (AP) +1.5 mm, mediolateral (ML) ±1.0 mm, dorsoventral 
(DV) −5.5 mm (Reynolds and Berridge, 2003). For the MPOA cannulation, the coordinates 
were set as: AP −0.5 mm, ML ± 0.75 mm, DV −6.5 mm (Guarraci et al., 2004; Small et al., 
2003). For the mPFC, the coordinates were: AP + 3.0 mm, ML ± 0.75 mm, DV −2.2 mm 
(Febo et al., 2010; Xie and Steketee, 2009).
Using a within-subjects Latin square design, 6 postpartum females rats were tested at 10 min 
after central infusion of VEH, MK 212 at 25, 75, or 250 ng/0.5μl/side on PP3, 5, 7, and 9 for 
the NAs study. For the MPOA, 7 rats were tested at 10 and 60 min after intra-MPOA 
infusion of VEH, 75 ng, 1.0 μg, or 5.0 μg/0.5μl/side of MK212 on PP 4, 6, 8 and 10, 
respectively. For the mPFC, two batches of 6 rats were tested under a lower (VEH, 25 ng, 
250 ng, 1.0 μg/0.5μl/side) and a higher dose range (VEH, 25 ng, 2.0 μg, 5.0 μg/0.5μl/side) 
using the same design as in the MPOA experiment. At the end of behavioral tests, rats were 
sacrificed and perfused. Their brains were sectioned and then stained with cresyl violet 
before viewing cannula placement as previous report (Feng et al., 2015). The location of the 
injection site was mapped onto a stereotaxic atlas (Paxinos, 2005) (Figure 1).
2.7. Experiment 4: Neural basis of MK212’s effects on maternal behavior: a c-Fos 
immunohistochemistry study
A total of 23 postpartum rats were randomly divided into one of four groups: repeated VEH 
(n = 6), repeated 2.0 mg/kg MK212 (n = 6), acute VEH (n = 5) and acute 2.0 mg/kg MK212 
(n = 6) group. This dose was chosen based on our previous work showing that acute 
injection of MK212 dose-dependently disrupts rat maternal performance with 2.0 mg/kg 
MK212 having the most disruption (Chen et al., 2014). For the repeated groups, maternal 
behavior was tested for 10 min once daily from PP 6 to 9 starting at 30 min after MK212 or 
VEH injection. For the acute groups, maternal behavior was only tested during PP 6 to 9 and 
no injection was done.
On PP 10, 1 h after the MK212 or VEH injection, all rats were deeply anesthetized and 
perfused as described in our previous work, and their brains were extracted for c-Fos 
immunoreactivity staining (Zhao and Li, 2010, 2012). Briefly, coronal sections were 
incubated with a rabbit polyclonal anti-c-Fos antibody (Ab-5, 1:20000 dilution, Calbiochem, 
CA, USA) for 48 h at 4°C. Sections were then incubated with a biotinylated goat anti-rabbit 
secondary antibody (1:200 dilution, Vector Laboratories, Burlingame, CA, USA) in PBS 
containing 1% normal goat serum for 2 h at RT. They were processed with avidin-biotin 
horseradish peroxidase complex (1:200 dilution, Vectastain Elite ABC Kit, Vector 
Laboratories). The immunoreaction was visualized with peroxidase substrate (DAB 
Substrate Kit for Peroxidase, Vector Laboratories). After staining, sections were mounted on 
gelatin-coated slides, air-dried, dehydrated and coverslipped. As a control, the primary 
antibody was substituted with normal goat serum. No corresponding nucleus or cytoplasm 
was immunostained in the control.
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Microscopic images were captured with a digital camera (INFINITY lite, Canada) furnished 
with an Olympus CX41RF microscope (Japan) using × 10 objective lens. The number of 
positive cells characterized by clearly labeled nuclei was counted unilaterally in six serial 
sections with comparable anatomical levels across the treatment groups. We focused on the 
NAs, mPFC, MPOA, dorsolateral striatum (DLSt), ventral part of lateral septal nucleus 
(LSv), central amygdala (CeA), ventral tegmental area (VTA), and dorsal raphe (DR), 
because 5-HT2A/2C receptor agonist (DOI) and antagonists (CLZ and olanzapine, OLZ) are 
shown to have effects on these regions in mother rats (Zhao and Li, 2010, 2012). DR was 
also chosen because it is a major serotonergic brain site (Azmitia and Segal, 1978; Liu et al., 
2000; Queree et al., 2009; Steinbusch, 1981). Other brain regions analyzed included the 
ventral bed nucleus of the stria terminalis (vBNST), medial amygdala (MeA), dentate gyrus 
(DG), and periaqueductal gray (PAG). The levels of brain slices were: Bregma 3.00 mm for 
mPFC, 1.92 mm for the NA and DLSt, 1.44 mm for the LSv, −0.24 for MPOA and vBNST, 
−2.92 mm for CeA, MeA and DG, −6.24 mm for VTA, and −7.92 mm for the PAG and DR 
according to Paxinos and Watson (Paxinos, 2005). With the help of ImageJ software, cell 
counts were made within a 1.8 × 1.8 mm2 unit area of each region of interest by an 
experimenter blind to the treatment condition. In a given area from distinct treatments, the 
images were threshold to the same value by means of eliminating background noise staining 
to ensure that the positive cells were selected. The number of cells in a given brain region 
from unilateral sites per rat were averaged. The values from each treatment group were 
averaged to obtain the final mean ± SEM.
2.8. Statistical analysis
Statistical analyses were performed using SPSS 20.0 software (SPSS Inc., Chicago, IL, 
USA). To examine the pup-separation and food-deprivation effects, data from the PP 4 and 
6, as well as PP 8 and 10 under the same testing condition (e.g. pup-separation on PP4 and 
6, food-deprivation on PP8 and 10) were combined and analyzed using repeated measures 
analysis of variance (AVOVA). Group differences at different test time points were further 
investigated using simple main effect tests (one-way ANOVA) followed by LSD post hoc 
tests for multiple comparisons where appropriate. Data from the experiments with a Latin 
square design were analyzed using Paired-Sample test. Repeated measures ANOVAs were 
conducted to examine the effects of repeated MK212 administration from PP 6 to 9. c-Fos 
Data were analyzed using multivariate analysis of variance in a 2×2 design (drug and 
treatment condition as between-subjects factors, brain regions as within-subjects factors), 
and significant effects were followed up using the LSD post hoc test comparing the within-
treatment condition across drug, and within-drug condition across treatment. Because the 
latency was not normally distributed, those data were analyzed using nonparametric 
Kruskal-Wallis test, and Mann-Whitney U test if the overall significant effects were 
determined. All data are presented as mean ± SEM. Differences were considered statistically 
significant if p < 0.05.
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3. Results
3.1. Experiment 1: Effect of pup separation on MK212-induced maternal disruption of pup 
retrieval: A comparison with food retrieval test
In agreement with our previous report (Chen et al., 2014), acute MK212 injection severely 
disrupted various active components of maternal behavior. In comparison to the VEH 
groups, rats treated with MK212 retrieved significantly fewer pups (all p < 0.001) and took a 
much longer time to complete pup retrievals (all p < 0.001) at the 30 min post injection 
testing point under both the pup separation and no separation conditions (Figure 2A and B). 
In addition, they also spent less time on pup nursing (all p < 0.001), licking (no-pup-
separation: p = 0.107; pup-separation: p = 0.001) and nest building (all p < 0.001) (Figure 
2C–E). Furthermore, pup separation was effective in increasing the amount of time spent by 
the mothers on nursing (all p < 0.001) and licking (VEH: p = 0.078; MK212: p = 0.003) and 
decreasing nest building (VEH: p = 0.051) at the baseline point, indicating the effectiveness 
of this procedure to increase maternal performance, possibly by increasing maternal 
motivation. More importantly, it significantly mitigated the MK212-induced pup retrieval 
deficit at the 30 min point, as evidenced by the increased number of pups retrieved (p = 
0.017) (Figure 2A) and decreased pup retrieval latency (p = 0.009) (Figure 2B) compared to 
the no-pup-separation + MK212 group.
At the baseline point, repeated measures ANOVA revealed a main effect of no-pup-
separation/pup-separation on pup nursing [F (1, 58) = 107.717, p < 0.001], licking [F (1, 58) 
= 12.829, p = 0.001], and nest building [F (1, 58) = 3.898, p = 0.053]. At the 30 min testing 
point, there was a significant main effect of drug treatment on pup retrieval [number of pups 
retrieved: F (1, 58) = 113.679, p < 0.001; latency of first pup retrieval: F (1, 58) = 123.774, p 
< 0.001], nursing [F (1, 58) = 113.929, p < 0.001], pup licking [F (1, 58) = 13.275, p = 
0.001], and nest building [F (1, 58) = 43.52, p < 0.001]; the interaction between two factors 
was also significant for pup retrieval [number of pups retrieved: F (1, 58) = 4.104, p = 0.047; 
latency of first pup retrieval: F (1, 58) = 4.808, p = 0.032]. There was no significant main 
effect of two factors or interaction between them on these parameters at 2 and 4 h testing 
points.
Acute MK212 treatment also disrupted food retrieval. The MK212-treated rats retrieved 
fewer chocolate flavored food pellets (all p < 0.001) and took a much longer time to retrieve 
them into the nest site (all p < 0.001) than the VEH rats at the 30 min, 2 h and 4 h testing 
points under both food-deprivation and no-food-deprivation conditions (Figure 3A and B). 
Six-hour food deprivation failed to alleviate these deficits (all p > 0.05) (Figure 3A and B), 
as there was no significant improvement in the number of food retrieved and first food 
retrieval latency. Repeated measures ANOVA revealed a significant main effect of drug 
treatment on the number of food retrieved [F (1, 58) = 89.458, p < 0.001 at 30 min; F (1, 58) 
= 103.053, p < 0.001 at 2 h; F (1, 58) = 31.072, p < 0.001 at 4 h] and latency of first food 
retrieval [F (1, 58) = 190.662, p < 0.001 at 30 min; F (1, 58) = 268.338, p < 0.001 at 2 h; F 
(1, 58) = 25.249, p < 0.001 at 4 h], but no significant effect of no-food-deprivation/food-
deprivation or interaction between the two factors.
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3.2. Experiment 2: Receptor specificity of MK212’s disruptive effect on pup retrieval
Pretreatment of SB242084 significantly improved the MK212-induced pup retrieval deficits. 
In comparison to the VEH-1 + VEH condition, rats under the VEH-1 + MK212 retrieved 
fewer pups into the nest at the 30 min (p = 0.014) and 60 min (p = 0.014) points. Pup 
retrieval improved only under the SB242084-0.6+MK212 (p = 0.046 at 30 min; p = 0.083 at 
60 min) conditions (Figure 4), but the differences between the SB242084-0.6/1.0 + MK212 
and VEH-1 + VEH were not significant (all p > 0.05 at 30 min and 60 min), indicating a 
relatively complete reversal.
3.3. Experiment 3: Neural basis of MK212’s effects on maternal behavior: a microinjection 
study
To examine the neuroanatomical basis of action of MK212 in maternal behavior, we 
microinjected MK212 at 25, 75, or 250 ng/side into the NAs. All the injection sites were 
verified in the intended targeted areas. Results showed that intra-NAs infusion of MK212 
had no effect on pup retrieval (all p > 0.05) (Figure 5A), as well as other maternal responses 
(e.g. pup licking, nursing and nest-building, data not shown). Similarly, intra-MPOA 
infusion of M212 at 75 ng, 1.0, and 5.0 μg/side also did not affect maternal performance. 
There was no significant difference among the four drug treatment conditions (all p > 0.05) 
(Figure 5B). Finally, both batches of dams with intra-mPFC injections of two dose ranges 
(batch 1: 25, 250 ng or 1 μg/side; batch 2: 25 ng, 2 or 5 μg/side) also did not show any 
difference in the number of pup retrievals and other maternal responses under any treatment 
condition (all p > 0.05) (Figure 5C).
3.4. Experiment 4: Neural basis of MK212’s effects on maternal behavior: a c-Fos 
immunohistochemistry study
Failure to identify any specific brain region that may mediate the MK212 effect on maternal 
behavior prompted us to use the c-Fos immunohistochemistry technique to map out a broad 
neural network. Behaviorally, we replicated the acute disruptive effect of MK212 on pup 
retrieval. In addition, we found that repeated MK212 treatment produced a persistent 
disruption of pup retrieval (all p < 0.05) (Figure 6A), as repeated measures ANOVA showed 
a significant main effect of drug treatment [F (1, 10) = 39.205, p < 0.001] on the number of 
pup retrieval across the 4 test days.
In comparison to the VEH treatment, acute MK212 treatment significantly decreased c-Fos 
immunoreactivity in the LSv (p = 0.025), MPOA (p = 0.035), DG (p = 0.007) and DR (p = 
0.011), but increased it in the CeA (p = 0.029). Repeated MK212 treatment only decreased 
c-Fos immunoreactivity in the DR (p = 0.021) (Figures 6B and C). Comparisons between 
acute and repeated MK212 treatments showed that repeated MK212 rats had significantly 
lower c-Fos immunoreactivity in the LSv (p = 0.017) and CeA (p = 0.011) than acute 
MK212 rats. Two-way ANOVA revealed a main effect of drug treatment on c-Fos 
immunoreactivity in the LSv [F (1, 19) = 20.642, p = 0.001], DG [F (1, 19) = 18.691, p = 
0.001], CeA [F (1, 19) = 13.512, p = 0.003], and DR [F (1, 19) = 15.679, p = 0.002], a main 
effect of acute/repeated treatment in the LSv [F (1, 19) = 13.465, p = 0.003], MPOA [F (1, 
19) = 4.802, p = 0.049] and VTA [F (1, 19) = 7.371, p = 0.019], and a significant interaction 
between the two factors in the MPOA [F (1, 19) = 5.257, p = 0.041], DG [F (1, 19) = 6.484, 
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p = 0.026], CeA [F (1, 19) = 7.789, p = 0.016] and VTA [F (1, 19) = 5.466, p = 0.038]. 
Interestingly, both acute and repeated MK212 did not affect c-Fos immunoreactivity in the 
mPFC, NAs, NAc, vBNST and MeA, brain regions previously implicated in the regulation 
of rat maternal behavior (Afonso et al., 2007; Brunton and Russell, 2008; Li and Fleming, 
2003b).
4. Discussion
The present study provided a comprehensive evaluation of various mechanisms of 5-HT2C 
agonism on maternal behavior. Specifically, we found that maternal behavior, especially pup 
retrieval, was severely disrupted at the 30 min testing point after MK212 injection (2.0 
mg/kg) and this disruption was attenuated to some extent by 4-h pup separation. In addition, 
acute MK212 treatment also significantly disrupted food retrieval at the 30 min, 2 h and 4 h 
time points after injection, and 6-h food deprivation was too weak to reverse this effect of 
MK212. These findings suggest that MK212 may have a general suppressive effect on 
motivated behaviors. Next, we showed that pretreatment of the 5-HT2C receptor antagonist 
SB242084 alleviated MK212-induced disruption in pup retrieval, confirming that MK212 
disrupts maternal behavior mainly through activating 5-HT2C receptors. Third, we failed to 
use the microinjection technique to identify specific brain sites in which 5-HT2C receptor 
exerts its maternal effect, as microinjection of a wide range of MK212 doses into the NAs, 
MPOA or mPFC did not cause any disruption in pup retrieval. However, the c-Fos 
immunohistochemistry technique was able to show that the 5-HT2C receptor in a neural 
network involving LSv, DG, CeA, MPOA, and DR is likely to play a role in maternal 
behavior, as acute MK212 altered c-Fos expression in the LSv, MPOA, CeA, DG and DR; 
and repeated MK212 further decreased c-Fos expression in the DR.
Chen et al. (2014) first reported that acute MK212 administration disrupts maternal 
responses in rats, especially for pup retrieval. Because pup retrieval is a proactive behavior 
of the dam and is usually used as an indicator of maternal motivation (Levy and Keller, 
2009), we speculated that MK212 may disrupt pup retrieval by suppressing maternal 
motivation. The findings that activation of 5-HT2C receptors can decrease dopamine release 
in the NAs and cell firing in the VTA are also consistent with this speculation (Di Giovanni 
et al., 2006; Di Matteo et al., 2002), as the mesolimbic dopamine system is known for its 
role in motivation and maternal behavior (Li and Fleming, 2003b; Numan, 2007) and other 
evidence suggests that 5-HT2C receptor agonism could decrease various motivated behaviors 
(Grauer et al., 2009; Higgins et al., 2012). To test this idea, we employed a pup-separation 
technique, which has been used to restore pup retrieval deficit induced by 6-OHDA lesions 
in the ventral striatum (Hansen, 1994). Four hours of pup-separation prior to the maternal 
behavior tests significantly attenuated the MK212-induced decrease in pup retrieval and 
shortened pup retrieval latency, without mitigation on other active maternal responses. This 
finding indicates that MK212 may disrupt maternal behavior by partially suppressing 
mothers’ motivation to take care of the young. It should be noted that because pup 
separation failed to completely reverse MK212-induced maternal deficits to the vehicle 
level, other behavioral effects of MK212 may also contribute to its maternal effect, such as 
its sedative effect or its motor suppression effect, as MK212 does induce hypolocomotion in 
rodents (Lucki et al., 1989; Stiedl et al., 2007). In addition, rats treated with MK212 were 
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not tested immediately after the 4-h separation (i.e., they had been with their mothers for 
about 1 h before the 1st MK212 test), and the 1-h reunion right after the 4-h pup separation 
might have attenuated the separation-induced increase in maternal motivation, leading to a 
reduced reversal. This might explain well why the pup separation employed in this study 
was not as effective as the one used in our previous study (Zhao and Li, 2009b), which did 
make the drug test coincided with the end of 4-h pup separation. At this moment, we could 
only conclude that there might be multiple behavioral mechanisms involved in the maternal 
disruptive effect of MK212.
Another way to study the potential effect of MK212 on maternal motivation is to compare its 
effect on other motivated behaviors. In this study, we used a food-hoarding test (Whishaw et 
al., 1990), which is similar to pup retrieval in terms of the required oral sensorimotor, 
incentive motivation, and sequential organization of motor acts. This task was chosen also 
because 5-HT2C receptors are well documented to be involved in the regulation of feeding 
behavior and food intake. Treatment with 5-HT1B/2C receptor agonist 1-(m-chlorophenyl) 
Piperazine (mCPP) produces behaviorally selective reductions in food intake in rats 
(Kitchener and Dourish, 1994), mice (Hewitt et al., 2002), and human (Sargent et al., 1997). 
The effects of mCPP on feeding in mice are also attenuated by SB242084 (Hewitt et al., 
2002). Selective 5-HT2C receptors agonists, including Ro 60-0175 and MK212, reduce 
feeding behavior (Clifton et al., 2000; Fletcher et al., 2009; Somerville et al., 2007; Vickers 
et al., 2000), while the 5-HT2C receptor antagonist RS100011 enhances food intake in rats 
(Bonhaus et al., 1997). 5-HT2C receptor agonists such as Ro 60-0175 are also found to 
reduce operant responding for food on fixed and progressive ratio schedules of 
reinforcement (Grottick et al., 2000), and on a second-order schedule of reinforcement 
(Somerville et al., 2007). Our observation that MK212 decreased chocolate pellets hoarding 
in rats is consistent with these findings, indicating that MK212 has a broad effect on reward 
(pup or food)-based motivated behaviors. Indeed, 5-HT2C agonists have shown a general 
inhibitory effect on various motivated behaviors, both natural and drug based (Fletcher et al., 
2012; Higgins and Fletcher, 2003; Higgins et al., 2013). However, the magnitude of 
MK212’s disruption appears to be behaviorally selective, as the food retrieval disruption 
persisted longer than that of pup retrieval: food retrieval disruption occurred at all the testing 
points, whereas the pup retrieval disruption occurred only at the 30 min point after the drug 
injection.
In Experiment 1, we found that 6-h food deprivation was unable to reverse MK212-induced 
deficit on food hoarding (carrying). This may be due to the fact that 6-h food deprivation 
during the light phase of the diurnal cycle was too weak to activate food motivation. In fact, 
earlier studies suggest that rats increase their food intake significantly following 2 to 6 hours 
of food deprivation at night, whereas the same food deprivation during the day cannot induce 
a change in subsequent food intake (Larue-Achagiotis and Le Magnen, 1982). It is not 
entirely clear how MK212 might cause a decrease in food motivation. One way is to cause 
satiation. It is known that activation of 5-HT2C receptors in the arcuate nucleus of the 
hypothalamus stimulates production of proopiomelanocortin, which is then cleaved into α-
melanocyte stimulating hormones. These hormones in turn act on the melanocortin 4 
receptor in the paraventricular nucleus of the hypothalamus to induce satiety (Clifton et al., 
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2000; Cone, 2005; Heisler et al., 2002; Somerville et al., 2007). MK212 might have this 
effect on the feeding center of hypothalamus.
As we mentioned, 5-HT2C agonists including MK212 have shown a general inhibitory effect 
on various motivated behaviors, both natural and drug based (Fletcher et al., 2012; Higgins 
and Fletcher, 2003; Higgins et al., 2013), it raises a question whether any of MK212’s 
effects is maternally specific. At present, we do not have any evidence to suggest that this is 
the case. Because 5-HT2C is such an important neuroreceptor for many brain and behavioral 
functions, even if MK212 has a maternal-specific effect, it is likely got masked by its global 
effect. The more likely scenario is that MK212 suppresses various psychological functions 
(e.g. emotion regulation, motivation, motoric response) that underlie various motivated 
behaviors (including maternal behavior). One important task for future research is to identify 
the maternal specific action of 5-HT2C receptor and its associated psychological functions.
MK212 binds to 5-HT2C receptors with high affinity, but it also has affinity for other 
receptors, such as 5-HT2A, 5-HT2B and 5-HT3 receptors (Cussac et al., 2002; Glennon et al., 
1989; Porter et al., 1999). To verify that the effects of MK212 on maternal responses were 5-
HT2C receptors mediated, we used a highly selective 5-HT2C receptor antagonist (Kennett et 
al., 1997), SB242084, and found it effectively reversed the maternal disruptive effects of 
MK212. Given that SB242084 is a high affinity antagonist for 5-HT2C receptor with 100-
fold and 158-fold selectivity over the 5-HT2B and 5-HT2A receptors, respectively (Kennett et 
al., 1997), and it by itself did not disrupt pup retrieval at 0.2, 0.6 and 1.0 mg/kg (unpublished 
data), the positive finding of SB242084 in blocking the effects of MK212 suggests that 
MK212-induced disruption of pup retrieval is mainly mediated by activating specific 5-
HT2C receptors. This finding is also in agreement with previous findings showing that 
central SB242084 injection can block the effects of MK212 on reinstatement of extinguished 
cocaine-seeking behavior (Pentkowski et al., 2010), and the effect of MK212 on the 
acquisition of inhibitory avoidance in the elevated T-maze (Yamashita et al., 2011).
Because the NAs and mPFC are densely populated with 5-HT2C receptors (Liu et al., 2007; 
Pompeiano et al., 1994); lesions of either the NAs or mPFC can cause pup retrieval deficits 
(Afonso et al., 2007; Li and Fleming, 2003b; Olazabal et al., 2013); and inactivation or 
inhibition of neuronal activity in the mPFC can disrupt maternal behavior (Febo et al., 
2010), we initially thought that microinjection of MK212 into these brain sites would cause 
a disruption of maternal behavior. This idea was also consistent with our previous c-Fos 
studies showing that the 5-HT2A/2C agonist DOI and antagonists CLZ and OLZ, though not 
selective to 5-HT2C receptors, increased c-Fos expression in the NAs and mPFC (Zhao and 
Li, 2010, 2012). The results here were contradictory to our expectation. In addition, 
microinjection of MK212 into the MPOA also failed to cause a pup retrieval disruption. 
There are several possible reasons that may explain these negative findings. First, it is 
possible that 5-HT2C receptors in these regions are not critical for the expression of maternal 
behavior. Other neuroreceptors such as dopamine D1 and D2 receptors are more important, 
as direct manipulation of these receptors in the NAs, mPFC and MPOA are shown to alter 
maternal care in rats (Numan et al., 2005; Numan and Stolzenberg, 2009). Second, the 
MK212 effect may require a coordinated change in 5-HT2C receptor activity in all these 
brain regions. Thus single manipulations of individual sites might not be the best way to 
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capture the systemic effects of MK212. This possibility is consistent with a previous 
functional magnetic resonance imaging study showing that pup stimuli induce a wide range 
of brain activation, including olfactory system, NAs, insular cortex, prefrontal cortex, VTA, 
cortical amygdala, and several cortical and hypothalamic nuclei (Febo et al., 2005). Third, 
other brain regions might be even more important than the above targeted sites (Barofsky et 
al., 1983a; Barofsky et al., 1983b). Raphe, as a serotonergic brain region, is important for the 
regulation of maternal behavior. DR 5-HT neurons project to the hypothalamus, and are 
involved in the suckling-induced prolactin release; whereas medial raphe (MR) 5-HT 
neurons directly influence maternal behavior (Barofsky et al., 1983a). It has been shown that 
MR lesions with 5,7-dihydroxytryptamine (5,7-DHT) cause a higher incidence of abnormal 
behaviors, including failure to retrieve pups, cannibalism, etc. than sham animals or animals 
with 5,7-DHT lesions in the DR or superior colliculus. Therefore, 5-HT2C in the MR 
nucleus may play a more critical role in the mediation of MK212 effects than other regions. 
This idea needs to be tested in the future study. Finally, the chosen doses of MK212 for 
central infusions may not be optimal. This possibility appears less likely as intra-mPFC 
infusion of MK212 in the dose ranges used here inhibits cocaine hyperactivity and 
attenuates cocaine reinstatement (Filip and Cunningham, 2003; Pentkowski et al., 2010). In 
addition, intra-NAc MK212 infusions in this dose range also enhance the effect of cocaine 
cues (Filip and Cunningham, 2002).
To provide a global view of the neural network where MK212 may act to achieve its 
maternal effect, we used c-Fos immunohistochemistry to map out the possible major sites 
that MK212 may act on. We observed greater Fos-immunoreactive nuclei in the CeA, and 
fewer Fos-immunoreactive nuclei in the LSv, MPOA, DG and DR following acute MK212 
treatment (Figure 6). In addition, repeated administration of MK212 further decreased c-Fos 
expression in the DR. These data suggest that the CeA, LSv, MPOA, DG and DR are at least 
partially involved in the action of MK212. Recent studies show that non-selective 5-HT2C 
receptor agonists Ro 60-0175 and mCPP inhibit the firing of 5-HT neurons in the DR 
(Queree et al., 2009), acting via neighboring gamma-aminobutric acid neurons (Liu et al., 
2000). Moreover, the serotonergic neurons in the DR project to the VTA and NAc, which 
may regulate maternal motivation toward the young (Bridges, 2015). Suckling stimuli are 
also processed through the DR by serotonergic inputs to the NA (Dolen et al., 2013). The 
CeA appears to be a crucial component for normal activation of maternal aggression 
circuitry and was shown to mediate the suppression of maternal care (Dulac et al., 2014). 
Maternal aggression was increased after microinjection of the 5-HT2A/2C receptor agonist α-
Methyl-5-hydroxytryptamine maleate into the amygdala (de Almeida et al., 2006). Taken 
together, we can suggest three neural systems where 5-HT2C receptor agonists such as 
MK212 may modulate maternal behavior. First, they could affect 5-HT2C receptor activity at 
the terminal sites of the mesolimbic, mesocortical and niagro-striatal dopamine pathways 
and modulate the neuronal activity of dopamine neurons and dopamine release (Alex and 
Pehek, 2007; Bailey et al., 2016). This activity is directly related to appetitive responses and 
willingness to exert effort toward a goal (Salamone et al., 2007). Second, they could interact 
with GABAergic and/or glutamatergic systems in the mPFC and regulate impulsivity and 
motivation (Dalley et al., 2008; Liu et al., 2007; Pentkowski et al., 2010). Finally, they could 
affect 5-HT2C receptors in the CeA, LSv, MPOA, DG and DR to alter maternal behavior. 
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Future research needs to be conducted to elucidate the exact central mechanisms of 5-HT2C 
receptor in maternal behavior.
In conclusion, the present study demonstrated that MK212 disrupts maternal behavior, and 
this disruption may reflect a general motivational suppressive effect of 5-HT2C agonism or 
its action on other unidentified processes. Future research is needed to determine the specific 
neural circuitry through which 5-HT2C receptor agonists produce the inhibitory effects on 
maternal care.
Acknowledgments
Role of funding source
This research was supported by a grant from the National Institute of Mental Health (5R01MH097718-02). The 
founding source had no further role in study design, in the collection, analysis and interpretation of data, in the 
writing of the report and in the decision to submit the paper for publication.
This research was supported in part by a grant from the National Institute of Mental Health (5R01MH097718-02). 
We want to thank the anonymous reviewers for their insightful comments which greatly improved the quality of this 
version of manuscript.
References
Afonso VM, Sison M, Lovic V, Fleming AS. Medial prefrontal cortex lesions in the female rat affect 
sexual and maternal behavior and their sequential organization. Behav Neurosci. 2007; 121:515–
526. [PubMed: 17592942] 
Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine 
neurotransmission. Pharmacol Ther. 2007; 113:296–320. [PubMed: 17049611] 
Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the 
dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978; 179:641–667. [PubMed: 565370] 
Bailey MR, Williamson C, Mezias C, Winiger V, Silver R, Balsam PD, Simpson EH. The effects of 
pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in mice. 
Psychopharmacology (Berl). 2016; 233:615–624. [PubMed: 26558617] 
Barofsky AL, Taylor J, Massari VJ. Dorsal raphe-hypothalamic projections provide the stimulatory 
serotonergic input to suckling-induced prolactin release. Endocrinology. 1983a; 113:1894–1903. 
[PubMed: 6685027] 
Barofsky AL, Taylor J, Tizabi Y, Kumar R, Jones-Quartey K. Specific neurotoxin lesions of median 
raphe serotonergic neurons disrupt maternal behavior in the lactating rat. Endocrinology. 1983b; 
113:1884–1893. [PubMed: 6685026] 
Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, 
Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglen RM. RS-102221: a novel high affinity and 
selective, 5-HT2C receptor antagonist. Neuropharmacology. 1997; 36:621–629. [PubMed: 9225287] 
Boulougouris V, Glennon JC, Robbins TW. Dissociable effects of selective 5-HT2A and 5-HT2C 
receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology. 2008; 
33:2007–2019. [PubMed: 17957219] 
Bridges RS. Neuroendocrine regulation of maternal behavior. Front Neuroendocrinol. 2015; 36:178–
196. [PubMed: 25500107] 
Brunton PJ, Russell JA. The expectant brain: adapting for motherhood. Nat Rev Neurosci. 2008; 9:11–
25. [PubMed: 18073776] 
Burghardt NS, Bush DE, McEwen BS, LeDoux JE. Acute selective serotonin reuptake inhibitors 
increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist. Biol Psychiatry. 
2007; 62:1111–1118. [PubMed: 17524369] 
Wu et al. Page 14
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Chen W, Zhang Q, Su W, Zhang H, Yang Y, Qiao J, Sui N, Li M. Effects of 5-hydroxytryptamine 2C 
receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in 
postpartum female rats. Pharmacol Biochem Behav. 2014; 117:25–33. [PubMed: 24321440] 
Clifton PG, Lee MD, Dourish CT. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist 
and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl). 2000; 152:256–
267. [PubMed: 11105935] 
Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005; 8:571–
578. [PubMed: 15856065] 
Cussac D, Newman-Tancredi A, Quentric Y, Carpentier N, Poissonnet G, Parmentier JG, Goldstein S, 
Millan MJ. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B 
receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. 
Naunyn Schmiedeberg’s Arch Pharmacol. 2002; 365:242–252. [PubMed: 11882920] 
Dalley JW, Mar AC, Economidou D, Robbins TW. Neurobehavioral mechanisms of impulsivity: 
fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav. 2008; 90:250–
260. [PubMed: 18272211] 
de Almeida RM, Giovenardi M, da Silva SP, de Oliveira VP, Stein DJ. The effect of 5-HT2a/2c receptor 
agonist microinjected into central amygdaloid nucleus and median preoptic area on maternal 
aggressive behavior in rats. Rev Bras Psiquiatr. 2006; 28:130–134. [PubMed: 16810397] 
de Mello Cruz AP, Pinheiro G, Alves SH, Ferreira G, Mendes M, Faria L, Macedo CE, Motta V, 
Landeira-Fernandez J. Behavioral effects of systemically administered MK-212 are prevented by 
ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. 
Psychopharmacology (Berl). 2005; 182:345–354. [PubMed: 16133141] 
Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E. Central serotonin2C receptor: from 
physiology to pathology. Curr Top Med Chem. 2006; 6:1909–1925. [PubMed: 17017966] 
Di Matteo V, Cacchio M, Di Giulio C, Esposito E. Role of serotonin 2C receptors in the control of 
brain dopaminergic function. Pharmacol Biochem Behav. 2002; 71:727–734. [PubMed: 11888564] 
Dolen G, Darvishzadeh A, Huang KW, Malenka RC. Social reward requires coordinated activity of 
nucleus accumbens oxytocin and serotonin. Nature. 2013; 501:179–184. [PubMed: 24025838] 
Dulac C, O’Connell LA, Wu Z. Neural control of maternal and paternal behaviors. Science. 2014; 
345:765–770. [PubMed: 25124430] 
Febo M, Felix-Ortiz AC, Johnson TR. Inactivation or inhibition of neuronal activity in the medial 
prefrontal cortex largely reduces pup retrieval and grouping in maternal rats. Brain Res. 2010; 
1325:77–88. [PubMed: 20156425] 
Febo M, Numan M, Ferris CF. Functional magnetic resonance imaging shows oxytocin activates brain 
regions associated with mother-pup bonding during suckling. J Neurosci. 2005; 25:11637–11644. 
[PubMed: 16354922] 
Feng M, Gao J, Sui N, Li M. Effects of central activation of serotonin 5-HT2A/2C or dopamine D2/3 
receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test. 
Psychopharmacology (Berl). 2015; 232:1219–1230. [PubMed: 25288514] 
Filip M, Cunningham KA. Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of 
the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav. 
2002; 71:745–756. [PubMed: 11888566] 
Filip M, Cunningham KA. Hyperlocomotive and discriminative stimulus effects of cocaine are under 
the control of serotonin(2C) (5-HT2C) receptors in rat prefrontal cortex. J Pharmacol Exp Ther. 
2003; 306:734–743. [PubMed: 12721337] 
Fleming AS, Corter C. Factors Influencing Maternal Responsiveness in Humans - Usefulness of an 
Animal-Model. Psychoneuroendocrinology. 1988; 13:189–212. [PubMed: 3287416] 
Fleming AS, Corter CM. Psychobiology of maternal behavior in nonhuman mammals. Handbook of 
parenting. 1995; 2:59–85.
Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Le AD, Higgins GA. Effects of the 5-HT2C 
receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-
administration and reinstatement. Neuropharmacology. 2012; 62:2288–2298. [PubMed: 22342986] 
Wu et al. Page 15
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fletcher PJ, Tampakeras M, Sinyard J, Slassi A, Isaac M, Higgins GA. Characterizing the effects of 5-
HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout 
mice. Neuropharmacology. 2009; 57:259–267. [PubMed: 19501602] 
Giordano AL, Johnson AE, Rosenblatt JS. Haloperidol-induced disruption of retrieval behavior and 
reversal with apomorphine in lactating rats. Physiol Behav. 1990; 48:211–214. [PubMed: 
2236274] 
Glennon RA, Ismaiel AE, McCarthy BG, Peroutka SJ. Binding of arylpiperazines to 5-HT3 serotonin 
receptors: results of a structure-affinity study. Eur J Pharmacol. 1989; 168:387–392. [PubMed: 
2583244] 
Grauer SM, Graf R, Navarra R, Sung A, Logue SF, Stack G, Huselton C, Liu Z, Comery TA, Marquis 
KL, Rosenzweig-Lipson S. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of 
current antipsychotics. Psychopharmacology (Berl). 2009; 204:37–48. [PubMed: 19107466] 
Grottick AJ, Fletcher PJ, Higgins GA. Studies to investigate the role of 5-HT2C receptors on cocaine- 
and food-maintained behavior. J Pharmacol Exp Ther. 2000; 295:1183–1191. [PubMed: 
11082456] 
Guarraci FA, Megroz AB, Clark AS. Paced mating behavior in the female rat following lesions of three 
regions responsive to vaginocervical stimulation. Brain Res. 2004; 999:40–52. [PubMed: 
14746920] 
Hansen S. Maternal behavior of female rats with 6-OHDA lesions in the ventral striatum: 
characterization of the pup retrieval deficit. Physiol Behav. 1994; 55:615–620. [PubMed: 8190785] 
Hansen S, Harthon C, Wallin E, Lofberg L, Svensson K. The effects of 6-OHDA-induced dopamine 
depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat. 
Pharmacol Biochem Behav. 1991; 39:71–77. [PubMed: 1924515] 
Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, 
Holstege H, Lee CE, Cone RD, Elmquist JK. Activation of central melanocortin pathways by 
fenfluramine. Science. 2002; 297:609–611. [PubMed: 12142539] 
Hewitt KN, Lee MD, Dourish CT, Clifton PG. Serotonin 2C receptor agonists and the behavioural 
satiety sequence in mice. Pharmacol Biochem Behav. 2002; 71:691–700. [PubMed: 11888560] 
Higgins GA, Fletcher PJ. Serotonin and drug reward: focus on 5-HT2C receptors. Eur J Pharmacol. 
2003; 480:151–162. [PubMed: 14623358] 
Higgins GA, Silenieks LB, Lau W, de Lannoy IA, Lee DK, Izhakova J, Coen K, Le AD, Fletcher PJ. 
Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and 
nicotine and on side effect profiles. Psychopharmacology (Berl). 2013; 226:475–490. [PubMed: 
23184281] 
Higgins GA, Silenieks LB, Rossmann A, Rizos Z, Noble K, Soko AD, Fletcher PJ. The 5-HT2C 
receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: 
relationship to feeding behavior and impulse control. Neuropsychopharmacology. 2012; 37:1177–
1191. [PubMed: 22189292] 
Keer S, Stern J. Dopamine receptor blockade in the nucleus accumbens inhibits maternal retrieval and 
licking, but enhances nursing behavior in lactating rats. Physiol Behav. 1999; 67:659–669. 
[PubMed: 10604835] 
Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, 
Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP. SB 242084, a selective and 
brain penetrant 5-HT2C receptor antagonist. Neuropharmacology. 1997; 36:609–620. [PubMed: 
9225286] 
Kitchener SJ, Dourish CT. An examination of the behavioural specificity of hypophagia induced by 5-
HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. 
Psychopharmacology (Berl). 1994; 113:369–377. [PubMed: 7862847] 
Larue-Achagiotis C, Le Magnen J. Effects of short-term nocturnal and diurnal food deprivation on 
subsequent feeding in intact and VMH lesioned rats: relation to blood glucose level. Physiol 
Behav. 1982; 28:245–248. [PubMed: 7200616] 
Levy F, Keller M. Olfactory mediation of maternal behavior in selected mammalian species. Behav 
Brain Res. 2009; 200:336–345. [PubMed: 19146885] 
Wu et al. Page 16
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Li M. Antipsychotic drugs on maternal behavior in rats. Behav Pharmacol. 2015; 26:616–626. 
[PubMed: 26221833] 
Li M, Budin R, Fleming AS, Kapur S. Effects of chronic typical and atypical antipsychotic drug 
treatment on maternal behavior in rats. Schizophr Res. 2005; 75:325–336. [PubMed: 15885524] 
Li M, Davidson P, Budin R, Kapur S, Fleming AS. Effects of typical and atypical antipsychotic drugs 
on maternal behavior in postpartum female rats. Schizophr Res. 2004; 70:69–80. [PubMed: 
15246466] 
Li M, Fleming AS. Differential involvement of nucleus accumbens shell and core subregions in 
maternal memory in postpartum female rats. Behav Neurosci. 2003a; 117:426–445. [PubMed: 
12802872] 
Li M, Fleming AS. The nucleus accumbens shell is critical for normal expression of pup-retrieval in 
postpartum female rats. Behav Brain Res. 2003b; 145:99–111. [PubMed: 14529809] 
Liu R, Jolas T, Aghajanian G. Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to 
serotonergic neurons of the dorsal raphe nucleus. Brain Res. 2000; 873:34–45. [PubMed: 
10915808] 
Liu S, Bubar MJ, Lanfranco MF, Hillman GR, Cunningham KA. Serotonin2C receptor localization in 
GABA neurons of the rat medial prefrontal cortex: implications for understanding the 
neurobiology of addiction. Neuroscience. 2007; 146:1677–1688. [PubMed: 17467185] 
Lucki I, Ward HR, Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-
trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther. 1989; 249:155–
164. [PubMed: 2709329] 
Numan M. Long-term effects of preoptic area knife cuts on the maternal behavior of postpartum rats. 
Behav Neural Biol. 1990; 53:284–290. [PubMed: 2331237] 
Numan M. Motivational systems and the neural circuitry of maternal behavior in the rat. Dev 
Psychobiol. 2007; 49:12–21. [PubMed: 17186513] 
Numan M, Corodimas KP. The effects of paraventricular hypothalamic lesions on maternal behavior in 
rats. Physiol Behav. 1985; 35:417–425. [PubMed: 2999841] 
Numan M, Numan MJ, Pliakou N, Stolzenberg DS, Mullins OJ, Murphy JM, Smith CD. The effects of 
D1 or D2 dopamine receptor antagonism in the medial preoptic area, ventral pallidum, or nucleus 
accumbens on the maternal retrieval response and other aspects of maternal behavior in rats. Behav 
Neurosci. 2005; 119:1588–1604. [PubMed: 16420162] 
Numan M, Rosenblatt J, Komisaruk BR. Medial preoptic area and onset of maternal behavior in the 
rat. J Comp Physiol Psychol. 1977; 91:146–164. [PubMed: 402400] 
Numan M, Stolzenberg DS. Medial preoptic area interactions with dopamine neural systems in the 
control of the onset and maintenance of maternal behavior in rats. Front Neuroendocrinol. 2009; 
30:46–64. [PubMed: 19022278] 
Olazabal DE, Pereira M, Agrati D, Ferreira A, Fleming AS, Gonzalez-Mariscal G, Levy F, Lucion AB, 
Morrell JI, Numan M, Uriarte N. Flexibility and adaptation of the neural substrate that supports 
maternal behavior in mammals. Neurosci Biobehav Rev. 2013; 37:1875–1892. [PubMed: 
23608126] 
Paxinos, GW. The rat brain in stereotaxic coordinates. Burlington MA: Elsevier Inc; 2005. 
Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC, Thiel KJ, Neisewander JL. 
Stimulation of medial prefrontal cortex serotonin 2C (5-HT2C) receptors attenuates cocaine-
seeking behavior. Neuropsychopharmacology. 2010; 35:2037–2048. [PubMed: 20520599] 
Pompeiano M, Palacios JM, Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: 
comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res. 1994; 23:163–178. 
[PubMed: 8028479] 
Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ. 
Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C 
receptors in CHO-K1 cells. Br J Pharmacol. 1999; 128:13–20. [PubMed: 10498829] 
Queree P, Peters S, Sharp T. Further pharmacological characterization of 5-HT2C receptor agonist-
induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo. Br J Pharmacol. 
2009; 158:1477–1485. [PubMed: 19845681] 
Wu et al. Page 17
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Reynolds SM, Berridge KC. Glutamate motivational ensembles in nucleus accumbens: rostrocaudal 
shell gradients of fear and feeding. Eur J Neurosci. 2003; 17:2187–2200. [PubMed: 12786986] 
Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens 
dopamine and associated forebrain circuits. Psychopharmacology (Berl). 2007; 191:461–482. 
[PubMed: 17225164] 
Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ. 5-HT2C receptor activation decreases 
appetite and body weight in obese subjects. Psychopharmacology (Berl). 1997; 133:309–312. 
[PubMed: 9361339] 
Silva MRP, Bernardi MM, Felicio LF. Effects of dopamine receptor antagonists on ongoing maternal 
behavior in rats. Pharmacol Biochem Behav. 2001; 68:461–468. [PubMed: 11325400] 
Small CJ, Goubillon ML, Murray JF, Siddiqui A, Grimshaw SE, Young H, Sivanesan V, Kalamatianos 
T, Kennedy AR, Coen CW, Bloom SR, Wilson CA. Central orexin A has site-specific effects on 
luteinizing hormone release in female rats. Endocrinology. 2003; 144:3225–3236. [PubMed: 
12810579] 
Somerville EM, Horwood JM, Lee MD, Kennett GA, Clifton PG. 5-HT2C receptor activation inhibits 
appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity 
in mice. Eur J Neurosci. 2007; 25:3115–3124. [PubMed: 17561825] 
Stack EC, Balakrishnan R, Numan MJ, Numan M. A functional neuroanatomical investigation of the 
role of the medial preoptic area in neural circuits regulating maternal behavior. Behav Brain Res. 
2002; 131:17–36. [PubMed: 11844569] 
Steinbusch HW. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-
cell bodies and terminals. Neuroscience. 1981; 6:557–618. [PubMed: 7017455] 
Stiedl O, Misane I, Koch M, Pattij T, Meyer M, Ogren SO. Activation of the brain 5-HT2C receptors 
causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. 
Neuropharmacology. 2007; 52:949–957. [PubMed: 17141810] 
Stolzenberg DS, McKenna JB, Keough S, Hancock R, Numan MJ, Numan M. Dopamine D1 receptor 
stimulation of the nucleus accumbens or the medial preoptic area promotes the onset of maternal 
behavior in pregnancy-terminated rats. Behav Neurosci. 2007; 121:907–919. [PubMed: 17907823] 
Stolzenberg DS, Zhang KY, Luskin K, Ranker L, Bress J, Numan M. Dopamine D1 receptor activation 
of adenylyl cyclase, not phospholipase C, in the nucleus accumbens promotes maternal behavior 
onset in rats. Horm Behav. 2010; 57:96–104. [PubMed: 19799904] 
Strong PV, Greenwood BN, Fleshner M. The effects of the selective 5-HT2C receptor antagonist SB 
242084 on learned helplessness in male Fischer 344 rats. Psychopharmacology (Berl). 2009; 
203:665–675. [PubMed: 19037632] 
Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT. Comparative effects of 
continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body 
weight and locomotor activity in rats. Br J Pharmacol. 2000; 130:1305–1314. [PubMed: 
10903970] 
Whishaw IQ, Oddie SD, McNamara RK, Harris TL, Perry BS. Psychophysical methods for study of 
sensory-motor behavior using a food-carrying (hoarding) task in rodents. J Neurosci Methods. 
1990; 32:123–133. [PubMed: 2366575] 
Xie X, Steketee JD. Effects of repeated exposure to cocaine on group II metabotropic glutamate 
receptor function in the rat medial prefrontal cortex: behavioral and neurochemical studies. 
Psychopharmacology (Berl). 2009; 203:501–510. [PubMed: 19005645] 
Yamashita PS, de Bortoli VC, Zangrossi H Jr. 5-HT2C receptor regulation of defensive responses in the 
rat dorsal periaqueductal gray. Neuropharmacology. 2011; 60:216–222. [PubMed: 20850460] 
Zhao C, Li M. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine 
on rat maternal behavior: A double dissociation between dopamine D2 and 5-HT2A/2C receptors. 
Pharmacol Biochem Behav. 2009a; 93:433–442. [PubMed: 19539643] 
Zhao C, Li M. Sedation and disruption of maternal motivation underlie the disruptive effects of 
antipsychotic treatment on rat maternal behavior. Pharmacol Biochem Behav. 2009b; 92:147–156. 
[PubMed: 19041338] 
Wu et al. Page 18
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Zhao C, Li M. C-Fos identification of neuroanatomical sites associated with haloperidol and clozapine 
disruption of maternal behavior in the rat. Neuroscience. 2010; 166:1043–1055. [PubMed: 
20096751] 
Zhao C, Li M. Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal 
behavior as revealed by c-Fos immunoreactivity. Pharmacol Biochem Behav. 2012; 103:174–180. 
[PubMed: 22960130] 
Wu et al. Page 19
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlights
• Pup separation attenuates acute MK212-induced deficit on pup 
retrieval.
• Acute MK212 inhibits food hoarding.
• SB242084 alleviates MK212-induced maternal disruption.
• Acute MK212 alters c-Fos expression in the LSv, MPOA, DG, DR and 
CeA.
• Repeated MK212 disrupts pup retrieval persistently and decreases DR 
activity.
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Figure 1. 
Histological representations of microinjection sites and schematic diagrams showing the 
location of the injector tips in the NAs, MPOA and mPFC. Data are reconstructed from 
Paxinos and Watson (Paxinos, 2005). Numbers to the left of the sections indicate 
anteroposterior distance from bregma in millimeters. The arrow in the histological 
representation section and black dot in the schematic diagrams denotes the infusion 
placement.
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Figure 2. 
Effects of systemic MK212 (2.0 mg/kg) on maternal behavior under 4-h pup-separation (PS, 
pups were taken away from dams 4 h before the test) and no-pup-separation (NS) conditions 
on PP 4 and 6. On each test day, maternal behavior was observed for 10 min at 4 time points: 
0.5 h before, 0.5, 2 and 4 h after the injection. On PP 4, mother rats were tested under two 
separation conditions. On PP 6, the rats tested in the pup-separation condition on Day 4 were 
tested in the no-pup-separation condition, and those previously tested in the no-pup-
separation condition were tested in the pup-separation condition. Data from the postpartum 
day 4 and 6 under the same condition (PS or NS) are combined and expressed as mean ± 
SEM. A, number of pup retrieved; B, latency of first pup retrieved; C, duration of pup 
nursing; D, duration of pup licking; E, duration of nest building; F, duration of pup sniffing. 
** p < 0.01, * p < 0.05 significantly different between the different drug administrations 
(VEH vs. MK212) within the same separation condition (PS or NS); ## p < 0.01, # p < 0.05 
significantly different between the different separation conditions (PS vs. NS) within the 
same drug exposure (VEH or MK212).
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Figure 3. 
Effects of systemic MK212 (2.0 mg/kg) on food retrieval under 6-h food-deprivation (FD) 
and no-food-deprivation (ND) conditions on postpartum day 8 and 10. Each retrieval test 
lasted 10 min. Number (A) and latency (B) of food retrieval from the postpartum day 8 and 
10 under the same condition (FD or ND) are combined and expressed as mean + SEM. * p < 
0.05, ** p < 0.01 significantly different between the different drug administrations (VEH vs. 
MK212) within the same deprivation treatment (FD or ND).
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Figure 4. 
Effects of acute MK212 (2.0 mg/kg) treatment on pup retrieval with pretreatment of 
SB242084 (0, 0.6, 1.0 mg/kg). SB242084 was injected 10 min before the MK212. Maternal 
behavior was tested for 10 min at 30 min before, 30 min, 60 min and 24 h after MK212 
injection. Number of pups retrieved in each test is expressed as mean + SEM. ** p < 0.01 
significantly different between the VEH-1 + VEH and − MK212 groups. # p < 0.05 
significantly different between SB242084 + MK212 and VEH-1 + MK212 groups.
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Figure 5. 
Effects of MK212 microinfused into the nucleus accumbens shell (NAs, A) on pup retrieval 
throughout the four test days (PP 3, 5, 7 and 9). Effects of MK212 microinfused into the 
medial preoptic area (MPOA, B) or medial prefrontal cortex (mPFC, C) on pup retrieval 
throughout the four test days (PP 4, 6, 8 and 10). Number of pups retrieval in each test is 
expressed as mean + SEM.
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Figure 6. 
A c-Fos immunohistochemistry study for the MK212 (2.0mg/kg) effects on maternal 
behavior. (A) Effects of repeated MK212 administration on the number of pup retrieved. 
Maternal behavior was tested for 10 min once daily from PP 6 to 9, with starting at 30 min 
after drug injection. (B) Effects of acute and repeated MK212 administration on c-Fos 
immunoreactivity. On PP 10, all rats were overdosed and perfused and their brains were 
extracted for c-Fos immunoreactivity staining 1 h after the drug injection. Number of anti-c-
Fos positive cells is expressed as mean + SEM. ** p < 0.01, * p < 0.05 significantly different 
between the VEH and MK212 in the same regimen (acute or repeated drug exposure); # p < 
0.05, ## p < 0.01 significantly different between the acute and repeated drug treatment in the 
same treatment condition (VEH or MK212). LSv, ventral lateral septum; CeA, central 
amygdala; MPOA, medial preoptic area; DG, dentate gyrus; DR, dorsal raphe; VTA, ventral 
tegmental area. (C), photomicrographs of immunohistochemistry showing c-Fos expression 
in the dorsal raphe. In comparison to the VEH groups, MK212 reduced the number of c-Fos 
immunoreactive neurons under both acute and repeated administration. (1), acute VEH; (2), 
acute 2.0mg/kg MK212; (3), repeated VEH; (4), repeated 2.0mg/kg MK212. Scale bar =100 
μm.
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